1  histone-histone cross-links and fluorescent advanced glycosylation end products.

2 reagent that cleaves DNA- and protein-linked advanced glycosylation end-products.

3 ls treated with aminoguanidine and two novel advanced glycosylation end products (AGE)-formation inhi

4                                              Advanced glycosylation end products (AGEs) form principa

5                                              Advanced glycosylation end products (AGEs) have been ide

6 ing of matrix proteins, as occurs because of advanced glycosylation end products (AGEs) in diabetes,

7 ctor-kappaB (NF-kappaB) by hyperglycemia and advanced glycosylation end products (AGEs).

8 ycosylation resulting in the accumulation of advanced glycosylation end products correlates with the

9              Our previous studies implicated advanced glycosylation end products in development of pr

10 cent products with properties similar to the advanced glycosylation end product pentosidine.

11 f SULF2 dysregulation in T2DM, we found that advanced glycosylation end products provoked a 10-fold i

12  decreases in the AEC I markers, T1alpha and advanced glycosylation end product-specific receptor.